Skip to content
My WebMD Sign In, Sign Up
Font Size

New Prostate Cancer Marker Found

Marker Is a Protein That May Predict Aggressive Prostate Cancer
By
WebMD Health News
Reviewed by Louise Chang, MD

Aug. 15, 2007 -- Scientists today announced that they have spotted a potential marker of aggressive prostate cancer.

The marker, called B7-H3, is a protein that's involved in the body's immune system.

Mayo Clinic doctors including Timothy Roth, MD, report that B7-H3 is more abundant in prostate cancers than in normal prostate tissue and is especially plentiful in aggressive prostate cancers.

Roth's team tested prostate tissue from 338 men with prostate cancer who had their prostates surgically removed between 1995 and 1998.

All of the men had B7-H3 in their prostate tumors. They also had B7-H3 in normal prostate tissue, to a lesser extent. The researchers tracked the men's prostate cancer for up to nine years.

During that time, prostate cancer worsened in 93 of the patients. Those patients generally had higher B7-H3 levels in their prostate tumors than men whose prostate cancer didn't worsen during the study period.

The researchers suggest that B7-H3 may help doctors gauge whether a patient has aggressive prostate cancer that needs early, aggressive treatment.

B7-H3 may also make a good target for new prostate cancer drugs, according to Roth and colleagues.

But don't expect that to happen right away. First, scientists must learn exactly what B7-H3 does and how to target it in prostate tumors without affecting healthy cells.

The study appears in the journal Cancer Research.

Today on WebMD

Prostate Cancer Overview
SLIDESHOW
what is your cancer risk
HEALTH CHECK
 
woman speaking with doctor
VIDEO
Prostate Nerve Transplant
VIDEO
 
cancer fighting foods
SLIDESHOW
15 Cancer Symptoms Men Ignore
FEATURE
 
Prostate Enlarged
VIDEO
Picture Of The Prostate
ANATOMY
 
Prostate Cancer Quiz
QUIZ
screening tests for men
SLIDESHOW
 
Prostate Cancer Symptoms
VIDEO
Vitamin D
SLIDESHOW